Inhaled therapy for COVID-19: Considerations of drugs, formulations and devices

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent responsible for the COVID-19 pandemic, has outspread at full tilt across the world. Although several effective vaccines continue to be deployed, reliable antiviral treatments have yet to be developed against this dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Saha, Tushar, Quiñones-Mateu, Miguel E., Das, Shyamal C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296254/
https://www.ncbi.nlm.nih.gov/pubmed/35868481
http://dx.doi.org/10.1016/j.ijpharm.2022.122042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296254/
https://www.ncbi.nlm.nih.gov/pubmed/35868481
http://dx.doi.org/10.1016/j.ijpharm.2022.122042

Ejemplares similares